ORASURE TECHNOLOGIES, INC Operating Lease Right-of-Use Assets
ORASURE TECHNOLOGIES, INC (OSUR) had Operating Lease Right-of-Use Assets of $11.09 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-07
- 2026-06-30: Operating Lease, Right-of-Use Asset $11.09M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $11.55M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $12.00M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $12.24M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $11.09M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $11.55M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $12.00M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $12.24M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $12.70M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $13.00M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $13.44M 10-K · filed 2026-03-09 |
| 2024-09-30 | $9.90M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $10.24M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $10.57M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $12.27M 10-K · filed 2025-03-07 |
| 2023-09-30 | $13.30M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $13.44M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $9.92M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $10.40M 10-K · filed 2024-03-11 |
| 2022-09-30 | $15.77M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $16.45M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $12.17M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $9.06M 10-K · filed 2023-03-03 |
| 2021-09-30 | $9.62M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $10.14M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $4.87M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.46M 10-K · filed 2022-03-01 |
| 2020-09-30 | $4.68M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $4.94M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $4.67M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $5.00M 10-K · filed 2021-03-01 |
| 2019-09-30 | $3.57M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $3.69M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $3.93M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |